Assessment of cholecystokinin 2 receptor (CCK2R) in neoplastic tissue

Lung Neoplasms Gastrointestinal Stromal Tumors Prognosis Receptor, Cholecystokinin B 3. Good health Gene Expression Regulation, Neoplastic Pancreatic Neoplasms Neuroendocrine Tumors 03 medical and health sciences 0302 clinical medicine Carcinoma, Non-Small-Cell Lung Case-Control Studies Neoplasms Biomarkers, Tumor Humans Neoplasm Invasiveness Thyroid Neoplasms Neoplasm Metastasis Research Paper Neoplasm Staging
DOI: 10.18632/oncotarget.7522 Publication Date: 2016-02-20T08:12:04Z
ABSTRACT
// Jyoti Roy 1, 2 , Karson S. Putt 1 Domenico Coppola 3 Marino E. Leon Farah K. Khalil Barbara A. Centeno Noel Clark 4 Valerie Stark 5 David L. Morse Philip Low Center for Drug Discovery, Purdue University, West Lafayette IN 47907 USA Department of Chemistry, Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa FL 33612 Tissue Core, Imaging and Metabolism, Technology Excellence, Correspondence to: Low, e-mail: plow@purdue.edu Keywords: cholecystokinin receptor, CCK2R, CCKBR, gastrin receptor Received: October 21, 2015 Accepted: January 29, 2016 Published: February 20, ABSTRACT The expression (CCK2R, CCKBR or receptor) has been reported on a diverse range cancers such as colorectal, liver, lung, pancreatic, ovarian, stomach, thyroid numerous neuroendocrine/carcinoid tumors. Some the colorectum, pancreas have shown to overexpress CCK2R in relation normal matched tissues same organ. This overexpression led development number CCK2R-ligand targeted imaging therapeutic agents. However, no comprehensive study comparing multiple performed. Herein, we report immunohistochemical analysis cancer samples from gastrointestinal stromal tumor (GIST), hepatocellular carcinoma (HCC), non-small cell lung (NSCLC), pancreatic adenocarcinoma, against tissue esophagus, pancreas, spleen thyroid. These results show that is present nearly all tested none had was statistically greater than samples.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (41)
CITATIONS (35)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....